Intricon to Announce 2021 First Quarter Results on Monday, May 10, 2021

Rhea-AI Summary

Intricon Corporation (NASDAQ: IIN) announced it will release its 2021 first quarter results on May 10, 2021, after market close. Following the announcement, a conference call with management is scheduled for 4:00 p.m. CT/5:00 p.m. ET on the same day. Investors can join the call by dialing (866) 795-7248 for domestic or (470) 495-9160 for international participants, using conference ID: 9769435. A live and archived webcast will also be available on the company’s website.

Intricon specializes in designing and manufacturing miniature medical devices and operates globally.

Positive

• Scheduled release of 2021 Q1 results could lead to increased investor interest.
• Management conference call allows direct engagement with investors.

Negative

• None.

ARDEN HILLS, Minn., April 26, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2021 first quarter results on Monday, May 10, 2021, after market close.

Following the release, Intricon’s management team will host a conference call on the same day, beginning at 4:00 p.m. CT/5:00 p.m. ET. Investors interested in listening to the conference call may do so by dialing (866) 795-7248 for domestic callers or (470) 495-9160 for international callers, using conference ID: 9769435. A live and archived webcast will be available on the “Investors” sections of the company’s website at: www.intricon.com.

About Intricon Corporation
Intricon is a Joint Development Manufacturer that integrates components and assemblies to advance micro-medical technology across a range of device platforms for global customers. Intricon approaches each engagement with an all-in commitment, working with customers every step of the way- from the earliest idea stages to ongoing production - in order to advance program performance and deliver results. With a focus on key device platforms, Intricon helps advance clinical outcomes by always looking ahead with proactive support and resources through integration of its core competencies. lntricon has facilities in the United States, Asia and Europe. The company's common stock trades under the symbol "IIN" on the NASDAQ Global Market.

Investor Relations Contact:
Leigh Salvo
(415) 937-5404
investorrelations@intricon.com

FAQ

When will Intricon release its 2021 first quarter results?

Intricon will release its 2021 first quarter results on May 10, 2021, after market close.

What time is the conference call following the Q1 results release for Intricon?

The conference call is scheduled for 4:00 p.m. CT/5:00 p.m. ET on May 10, 2021.

How can investors join Intricon's conference call?

Investors can join by dialing (866) 795-7248 for domestic or (470) 495-9160 for international calls, using conference ID: 9769435.

Where can I find the webcast for Intricon's conference call?

The live and archived webcast will be available on the 'Investors' section of Intricon's website.

What is Intricon Corporation known for?

Intricon specializes in designing, developing, and manufacturing miniature interventional and implantable medical devices.